When a great opportunity comes along, you don’t pass it up — even if it happened much sooner than anticipated. That’s the mindset Jennifer Greenman adopted when, in September of 2014, she was promoted to CIO at Moffitt Cancer Center when Mark Hulse took on the role of Chief Administrative Officer. The plan for Greenman, who was hired as senior director of application services, was to succeed Hulse eventually, and so even though it was an accelerated path, it was still one she happily took. In this interview, she talks about the innovative work being done through the Total Cancer Care initiative, the proactive approach she takes with security education, how Moffitt hopes to continue to improve patient engagement, and the biggest challenge in stepping into the CIO role.
Chapter 1
* About Moffitt Cancer Center
* TCC — “It’s an essential part of our care delivery and research model.”
* Oncology Research Information Exchange Network
* Taking Chemo paperless — “It’s one of the most complex aspects of the EHR.”
* Commitment to personalized medicine
* The steep oncology learning curve
LISTEN NOW USING THE PLAYER BELOW OR CLICK HERE TO SUBSCRIBE TO OUR iTUNES PODCAST FEED
Bold Statements
Researchers at ORIEN member institutions are able to securely access de-identified data through the consortium’s centralized data warehouse to support discovery of new biomarkers and targeted cancer treatments across this large data set — analysis that is especially important for rare cancers and molecular profiles.
It’s a tremendous part of the care delivery that Moffitt provides, so we think it’s very important to intentionally take the time to properly design, build, test and ensure that all the workflows are as precise and optimal as possible to ensure patient safety and clinical efficiency.
The data storage requirements are significant, and the types of data models necessary to integrate these data are highly complex and really require a different type of skill set and expertise than perhaps traditional data management tools and processes have permitted.
We’re all learning. It’s extraordinarily exciting, and the potential for these technologies in all of healthcare — and notably in oncology care — is tremendous. But we’re definitely taking measures to develop the knowledge and skills to be able to enable the use of these innovative technologies in the future.
Gamble: Hi Jennifer, thank you so much for taking some time to speak with healthsystemCIO.com.
Greenman: My pleasure.
Gamble: To get things started, let’s get some information about Moffitt Cancer Center, first in terms of number of hospital beds but then some of what you do on the ambulatory side.
Greenman: The H. Lee Moffitt Cancer Center and Research Institute was established by the Florida legislature in 1981 and opened its doors in 1986. Our organization was founded on a singular mission, which is to contribute to the prevention and cure of cancer, and this mission is deeply ingrained into our culture and practice. In 2001, we were honored to be designated by the National Cancer Institute as a comprehensive cancer center, and currently we are the only NCI-designated comprehensive cancer center in the state of Florida.
Moffitt delivers patient care across three campuses in Tampa, Florida. Our Magnolia campus, which is located at the University of South Florida, includes a 206-bed acute care hospital, as well as a large outpatient clinic and research space. We have, in fact, over 220,000 square feet of wet and dry lab space here on-campus. We also deliver comprehensive outpatient services at two satellite locations: Moffitt at International Plaza and Moffitt McKinley campus.
In 2015, we treated over 54,000 patients across 346,000 outpatient visits in our disease-oriented interdisciplinary p...